Monoclonal antibody treatment of colorectal cancer

This publication has 80 references indexed in Scilit:

• Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity
  British Journal of Cancer, 1995
• m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer
  British Journal of Cancer, 1994
• Anti-idotype and recombinant antigen in immunotherapy of colorectal cancer
  Cell Biochemistry and Biophysics, 1994
• Radioimmunolocation of Hepatic and Pulmonary Metastasis of Human Colon Adenocarcinoma
  Gastroenterology, 1989
• Occult blood screening for colorectal carcinoma: A critical review
  Gastroenterology, 1985
• Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
  The Journal of Experimental Medicine, 1985
• Human Macrophages Armed with Murine Immunoglobulin G2a Antibodies to Tumors Destroy Human Cancer Cells
  Science, 1983
• IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
  Proceedings of the National Academy of Sciences, 1982
• Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.
  Proceedings of the National Academy of Sciences, 1980
• Continuous cultures of fused cells secreting antibody of predefined specificity
  Nature, 1975